Menu
ncarol.com
  • Home
  • Business
  • Health
  • Real Estate
  • Arts
  • Non-profit
  • Education
  • Technology
  • Books
ncarol.com

Galaxy Diagnostics Launches Broadest IFA Serology Panel Available for Bartonella Infection
ncarol.com/10129159

Trending...
  • New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
  • Why Regular Visits to a Dentist in Kernersville Protect More Than Just Your Smile
  • SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
Ifa Pr Post Only Bartonella test that detects 4 species Identifies Bartonella cases missed by other tests Galaxy Diagnostics Go Beyond the Limits Buttershop Digital Agency
Science Leader in the Testing of Flea and Tick-Borne Illness Introduces 4 Species IgG Antibody Test Panel for Bartonella Infection

DURHAM, N.C. - ncarol.com -- Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, today announced the launch of the most comprehensive Bartonella IFA Serology (IgG) Panel commercially available for human health testing.

This expanded antibody test panel provides evidence of exposure to four zoonotic Bartonella species: Bartonella henselae, Bartonella quintana, Bartonella koehlerae, and Bartonella vinsonii berkhoffii. With over 30 identified species and more than 10 species implicated in human disease, Bartonella species infection is one of the more important emerging infectious diseases on the clinical radar today.

Bartonella species are known to cause a range of diseases in people, including cat scratch disease, trench fever, culture negative endocarditis, rheumatologic disease, neurobartonellosis, vasoproliferative tumors, optic neuritis and other diseases. The new four species panel provides important advantages over standard antibody testing, namely:
  • Identifies positive cases missed by conventional antibody testing
  • Detects IgG antibodies against 4 most common Bartonella species implicated in human disease
  • Advances Bartonella testing for high-risk populations, such as veterinary workers
Indirect immunofluorescence assay (IFA) testing for bartonellosis determines the presence or absence of antibodies to a single Bartonella species within patient serum samples. Clinically, measured antibody levels (titers) are considered to be indicative of an individual's prior exposure or current immune response against a specific pathogen. The presence of antibodies indicates that a patient has been exposed to a particular species of Bartonella. High titers against a Bartonella species are indicative of active infection, according to established medical guidelines for cat scratch disease and Bartonella endocarditis.

More on ncarol.com
  • Hilton Charlotte Uptown Hosts First-Ever Premium Tailgate Experience
  • Assent Expands Executive Team to Accelerate Global Growth & Innovation
  • The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
  • Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
  • Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft

"Advancing the sensitivity of existing test offerings is central to our mission to bring the most scientifically advanced diagnostic test options to the forefront of flea and tick-borne disease", said Galaxy CEO Amanda Elam. "Bartonella species infection represents an important and fast-growing area of emerging infectious disease. A growing body of published research suggests these pathogens play a key role in chronic illness, from cancer etiology to heart and liver infection, especially for those individuals with high exposure to fleas, ticks, lice, and animals. We are committed to improving the broadest, most sensitive and specific test options for these elusive, low abundance pathogens. The path to better patient care in this area of emerging infectious disease starts with more reliable and accurate testing developed by global experts in flea and tick-borne disease."

Galaxy advocates for a new standard of care in Bartonellosis testing and recommends a combination diagnostic protocol with Bartonella Digital ePCR™ to confirm active infection and the newly expanded Bartonella IFA Serology Panel to detect the presence of IgG antibodies.

You can order here and learn more at galaxydx.com.

More on ncarol.com
  • Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
  • Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
  • $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
  • Marvelous Mouse Talk Named One of the Top 100 Disney Podcasts by MillionPodcasts
  • Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital

About Galaxy Diagnostics


Galaxy Diagnostics is a privately held medical laboratory located in Research Triangle Park offering the only testing solutions powered by revolutionary sample enrichment technologies for elusive flea and tick borne pathogens. The company's mission is to "Go Beyond" the limits of conventional detection by driving scientific innovation, creating new clinical knowledge through research and publication, and providing medical education and excellent customer support to healthcare providers, veterinarians, patients, and research customers in this important area of emerging infectious disease.

Contact
James Rebenski
***@galaxydx.com


Source: Galaxy Diagnostics, Inc.
Filed Under: Business, Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
  • Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
  • Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
  • Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
  • Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
  • Magical Creatures Hit the Hallways in Captain Cougar Goes to School
  • Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
  • Hinuera Properties and The Sage Plant Announce Modern Townhome Project in the Piedmont Triad
  • The Sage Plant Drives PropTech in the Piedmont Triad
  • NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
  • Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
  • Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
  • SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
  • From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
  • Veterans for America First's Vet Force community outreach is expanding said David Draper VFAF
  • New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
  • Why Regular Visits to a Dentist in Kernersville Protect More Than Just Your Smile
  • O2 Fitness Opens New Signature Location in Pittsboro, NC
  • Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
  • Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
_catLbl0 _catLbl1

Popular on ncarol.com

  • Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 124
  • csky.ai & DuoKey Launch Secure AI Transcription Solution for Microsoft 365
  • Mauro Schnaidman named as Managing Director in Miami, Florida
  • Continued Streak of Recognitions with Multiple Chambers and Partners Rankings
  • Innovative EDM Music Project, "Terms of War," Depicts an A.I. Takeover of Earth
  • LIB Continuous Innovation: Custom Rain Test Chambers & IP Labs
  • Local Clinic Fills the Gaps Politicians Don't Want to Talk About
  • Jeopardy!'s Ken Jennings Headlines National Mensa Event
  • OPRAH.COM Featured Award-Winning Novel AS FAR AS YOU GO BEFORE YOU HAVE TO COME BACK now Available as Audiobook
  • Mensa Foundation Prize Awarded to Neuroscientist-Pianist

Similar on ncarol.com

  • Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
  • Colbert Packaging Announces WBENC Recognition
  • DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
  • Assent Expands Executive Team to Accelerate Global Growth & Innovation
  • The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
  • Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
  • Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
  • Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
  • Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
  • Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute